Drug Discovery World

APRIL 6, 2023

Programme highlights The topic tracks include everything from clinical trials, drug development, immunology and bioinformatics, to global health, survivorship, prevention and tumour biology, to name just a few. Science ↔ Survivor Program As mentioned previously, AACR has a Scientist↔Survivor Program.

Small Molecule 130

Small Molecule Targeted Protein Degradation Clinical Trials Engineering 130

Drug Discovery World

JULY 11, 2023

These different fundamental approaches (rules-based versus pattern recognition) to building these systems provide multiple opportunities to interject them into disease diagnostics and treatments. How AI and ML are influencing drug development Biopharma has experienced significant growth in using these technologies for the past 10 years.

Science 100

Science Drugs FDA Engineering 100

Agency IQ

OCTOBER 12, 2023

Joneckis said that CBER has “some limited uses that we have seen in external submissions, mostly in the bioinformatics area,” but not as many as CDER. Regarding artificial intelligence (AI), an important topic at RAPS Convergence, the two centers discussed external and internal use cases.

FDA 40

FDA Clinical Trials International Drugs 40

Nvidia Developer: Drug Discovery

DECEMBER 19, 2023

HiFi-NN annotates protein sequences with enzyme commission (EC) numbers beating the current bioinformatics tool of choice ( blastp ), as well as other SoTA DL models, including CLEAN , in precision and recall (Table 1). Trained on eight NVIDIA A100 GPUs on a Lambda Labs instance with CUDA version 11.8 and NCCL version 2.14.3,

Small Molecule 131

Small Molecule Science Bioinformatics Research 131

Broad Institute

JULY 10, 2023

Alicia Martin and attendees of the KEMRI-Wellcome Trust/GINGER Bioinformatics training in Kilifi, Kenya in September 2018. Alicia Martin, Allan Kalungi (Makerere University), and Lerato Majara (University of Cape Town) work together on a research project at the 2018 GINGER workshop held in London, UK.

Bioinformatics 98

Bioinformatics Medical Schools Disease Research 98

Drug Discovery World

NOVEMBER 15, 2022

Developing therapeutic antibodies, one of the most successful approaches in drug development, involves identifying and characterising antibodies to be used as treatment against different types of cancers as well as autoimmune and cardiovascular diseases. Synthetic libraries for antibody drug discovery .

DNA 246

DNA Engineering Drugs Vaccine 246